Morning Overview on MSN
The FDA approved the first gene therapy for sickle cell in children as young as two
Regulators have opened a one-time gene therapy to some of the youngest patients with sickle cell disease. On July 1, 2026, ...
The Food and Drug Administration recently approved gene therapy to treat sickle cell disease among children ages 2 and older, which a Nashville doctor described as a medical milestone.
CSL is investigating two potential new treatments for sickle cell disease: An injected monoclonal antibody designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results